{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:54:35Z","timestamp":1785196475961,"version":"3.55.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T00:00:00Z","timestamp":1446249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s40257-015-0164-2","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T04:43:24Z","timestamp":1446266604000},"page":"23-32","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Efficacy and Safety of 308-nm Monochromatic Excimer Lamp Versus Other Phototherapy Devices for Vitiligo: A Systematic Review with Meta-Analysis"],"prefix":"10.1007","volume":"17","author":[{"given":"Celso","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia Fernandes Mo\u00e7a","family":"Trevisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Melnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,31]]},"reference":[{"key":"164_CR1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.clindermatol.2013.11.011","volume":"32","author":"T Lotti","year":"2014","unstructured":"Lotti T, D\u2019Erme AM. Vitiligo as a systemic disease. Clin Dermatol. 2014;32:430\u20134.","journal-title":"Clin Dermatol."},{"key":"164_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00403-015-1544-4","volume":"307","author":"GZ Ding","year":"2015","unstructured":"Ding GZ, Zhao WE, Li X, Gong QL, Lu Y. A comparative study of mitochondrial ultrastructure in melanocytes from perilesional vitiligo skin and perilesional halo nevi skin. Arch Dermatol Res. 2015;307:281\u20139.","journal-title":"Arch Dermatol Res."},{"key":"164_CR3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","volume":"38","author":"R Yaghoobi","year":"2011","unstructured":"Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the published work. J Dermatol. 2011;38:419\u201331.","journal-title":"J Dermatol."},{"key":"164_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386:74\u201384.","journal-title":"Lancet."},{"key":"164_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","volume":"168","author":"A Taieb","year":"2013","unstructured":"Taieb A, Alomar A, B\u00f6hm M, Dell\u2019anna ML, De Pase A, Eleftheriadou V, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168:5\u201319.","journal-title":"Br J Dermatol."},{"key":"164_CR6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","volume":"65","author":"A Alikhan","year":"2011","unstructured":"Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview. Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65:473\u201391.","journal-title":"J Am Acad Dermatol."},{"key":"164_CR7","doi-asserted-by":"crossref","unstructured":"Teovska Mitrevska N, Eleftheriadou V, Guarneri F. Quality of life in vitiligo patients. Dermatol Ther. 2012;25:S28\u201331.","DOI":"10.1111\/dth.12007"},{"key":"164_CR8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000350781","volume":"44","author":"F Sampogna","year":"2013","unstructured":"Sampogna F. Life course impairment and quality of life over time. Curr Probl Dermatol. 2013;44:47\u201351.","journal-title":"Curr Probl Dermatol."},{"key":"164_CR9","doi-asserted-by":"crossref","unstructured":"Mishra N, Rastogi MK, Gahalaut P, Agrawal S. Dermatology specific quality of life in vitiligo patients and its relation with various variables: a hospital based cross-sectional study. J Clin Diagn Res. 2014;8:YC01\u20133.","DOI":"10.7860\/JCDR\/2014\/8248.4508"},{"key":"164_CR10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2340\/00015555-1981","volume":"95","author":"C Kr\u00fcger","year":"2015","unstructured":"Kr\u00fcger C, Schallreuter KU. Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo. Acta Derm Venereol. 2015;95:553\u20138.","journal-title":"Acta Derm Venereol."},{"key":"164_CR11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bjd.13839","volume":"173","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Grimes PE, Meurant JM, Seneschal J, L\u00e9aut\u00e9-Labr\u00e8ze C, Ballanger F, et al. Living with vitiligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol. 2015;173:607\u20139.","journal-title":"Br J Dermatol."},{"key":"164_CR12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40257-013-0037-5","volume":"14","author":"GA Bin Saif","year":"2013","unstructured":"Bin Saif GA, Al-Balbeesi AO, Binshabaib R, Alsaad D, Kwatra SG, Alzolibani AA, et al. Quality of life in family members of vitiligo patients: a questionnaire study in Saudi Arabia. Am J Clin Dermatol. 2013;14:489\u201395.","journal-title":"Am J Clin Dermatol."},{"key":"164_CR13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2310\/7750.2012.12005","volume":"17","author":"N Malhotra","year":"2013","unstructured":"Malhotra N, Dytoc M. The pathogenesis of vitiligo. J Cutan Med Surg. 2013;17:153\u201372.","journal-title":"J Cutan Med Surg."},{"key":"164_CR14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5114\/pdia.2014.43497","volume":"31","author":"R Czajkowski","year":"2014","unstructured":"Czajkowski R, M\u0119ci\u0144ska-Jundzi\u0142\u0142 K. Current aspects of vitiligo genetics. Postepy Dermatol Alergol. 2014;31:247\u201355.","journal-title":"Postepy Dermatol Alergol."},{"key":"164_CR15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1346-8138.12147","volume":"40","author":"RA Spritz","year":"2013","unstructured":"Spritz RA. Modern vitiligo genetics sheds new light on an ancient disease. J Dermatol. 2013;40:310\u20138.","journal-title":"J Dermatol."},{"key":"164_CR16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/039463201402700403","volume":"27","author":"A Ghafourian","year":"2014","unstructured":"Ghafourian A, Ghafourian S, Sadeghifard N, Mohebi R, Shokoohini Y, Nezamoleslami S, et al. Vitiligo: symptoms, pathogenesis and treatment. Int J Immunopathol Pharmacol. 2014;27:485\u20139.","journal-title":"Int J Immunopathol Pharmacol."},{"key":"164_CR17","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.autrev.2014.12.003","volume":"14","author":"R Speeckaert","year":"2015","unstructured":"Speeckaert R, Speeckaert MM, van Geel N. Why treatments do(n\u2019t) work in vitiligo: an autoinflammatory perspective. Autoimmun Rev. 2015;14:332\u201340.","journal-title":"Autoimmun Rev."},{"key":"164_CR18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11318020-000000000-00000","volume":"12","author":"X Lin","year":"2011","unstructured":"Lin X, Tang LY, Fu WW, Kang KF. Childhood vitiligo in China: clinical profiles and immunological findings in 620 cases. Am J Clin Dermatol. 2011;12:277\u201381.","journal-title":"Am J Clin Dermatol."},{"key":"164_CR19","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/exd.12372","volume":"23","author":"NC Laddha","year":"2014","unstructured":"Laddha NC, Dwivedi M, Mansuri MS, Singh M, Gani AR, Yeola AP, et al. Role of oxidative stress and autoimmunity in onset and progression of vitiligo. Exp Dermatol. 2014;23:352\u20133.","journal-title":"Exp Dermatol."},{"key":"164_CR20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2310\/7750.2014.14076","volume":"19","author":"H Zedan","year":"2015","unstructured":"Zedan H, Abdel-Motaleb AA, Kassem NM, Hafeez HA, Hussein MR. Low glutathione peroxidase activity levels in patients with vitiligo. J Cutan Med Surg. 2015;19:144\u20138.","journal-title":"J Cutan Med Surg."},{"key":"164_CR21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5021\/ad.2015.27.2.178","volume":"27","author":"G G\u00fcnta\u015f","year":"2015","unstructured":"G\u00fcnta\u015f G, Engin B, Ekmek\u00e7i \u00d6B, Kutlubay Z, Ekmekci H, Song\u00fcr A, et al. Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients. Ann Dermatol. 2015;27:178\u201383.","journal-title":"Ann Dermatol."},{"key":"164_CR22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40257-013-0039-3","volume":"14","author":"CR Camara-Lemarroy","year":"2013","unstructured":"Camara-Lemarroy CR, Salas-Alanis JC. The role of tumor necrosis factor-\u03b1 in the pathogenesis of vitiligo. Am J Clin Dermatol. 2013;14:343\u201350.","journal-title":"Am J Clin Dermatol."},{"key":"164_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2133.2010.10039.x","volume":"164","author":"R Kumar","year":"2011","unstructured":"Kumar R, Parsad D, Kanwar AJ. Role of apoptosis and melanocytorrhagy: a comparative study of melanocyte adhesion in stable and unstable vitiligo. Br J Dermatol. 2011;164:187\u201391.","journal-title":"Br J Dermatol."},{"key":"164_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0378-6323.90942","volume":"78","author":"R Kumar","year":"2012","unstructured":"Kumar R, Parsad D. Melanocytorrhagy and apoptosis in vitiligo: connecting jigsaw pieces. Indian J Dermatol Venereol Leprol. 2012;78:19\u201323.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"164_CR25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2310\/7750.2013.12053","volume":"17","author":"AJ Kanwar","year":"2013","unstructured":"Kanwar AJ, Mahajan R, Parsad D. Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. J Cutan Med Surg. 2013;17:259\u201368.","journal-title":"J Cutan Med Surg."},{"key":"164_CR26","doi-asserted-by":"crossref","unstructured":"Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, Gonz\u00e1lez U, Jiyad Z, et al. Interventions for vitiligo. Cochrane Database Syst Rev. 2015;2:CD003263. doi: 10.1002\/14651858.CD003263.pub5 .","DOI":"10.1002\/14651858.CD003263.pub5"},{"key":"164_CR27","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/1346-8138.12283","volume":"40","author":"J Du","year":"2013","unstructured":"Du J, Wang XY, Ding XL, Xu QX, Chen Z, Chang JM, et al. Long-term efficacy and safety of tacrolimus ointment in the treatment of vitiligo. J Dermatol. 2013;40:935\u20136.","journal-title":"J Dermatol."},{"key":"164_CR28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/jid.2014.527","volume":"135","author":"M Cavali\u00e9","year":"2015","unstructured":"Cavali\u00e9 M, Ezzedine K, Fontas E, Montaudi\u00e9 H, Castela E, Bahadoran P, et al. Maintenance therapy of adult vitiligo with 0.1\u00a0% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol. 2015;135:970\u20134.","journal-title":"J Invest Dermatol."},{"key":"164_CR29","first-page":"256","volume":"88","author":"MD Newman","year":"2011","unstructured":"Newman MD, Silverberg NB. Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo. Cutis. 2011;88:256\u20139.","journal-title":"Cutis."},{"key":"164_CR30","first-page":"373","volume":"146","author":"A Hossani-Madani","year":"2011","unstructured":"Hossani-Madani A, Halder R. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes. G Ital Dermatol Venereol. 2011;146:373\u201395.","journal-title":"G Ital Dermatol Venereol."},{"key":"164_CR31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-4632.2012.05697.x","volume":"52","author":"R Wong","year":"2013","unstructured":"Wong R, Lin AN. Efficacy of topical calcineurin inhibitors in vitiligo. Int J Dermatol. 2013;52:491\u20136.","journal-title":"Int J Dermatol."},{"key":"164_CR32","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jamadermatol.2014.4951","volume":"151","author":"HW Lim","year":"2015","unstructured":"Lim HW, Grimes PE, Lebwohl M. Indications and limitations of afamelanotide for treating vitiligo-reply. JAMA Dermatol. 2015;151:350.","journal-title":"JAMA Dermatol."},{"key":"164_CR33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","volume":"151","author":"HW Lim","year":"2015","unstructured":"Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, et al. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. JAMA Dermatol. 2015;151:42\u201350.","journal-title":"JAMA Dermatol."},{"key":"164_CR34","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjd.12325","volume":"169","author":"C Singh","year":"2013","unstructured":"Singh C, Parsad D, Kanwar AJ, Dogra S, Kumar R. Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study. Br J Dermatol. 2013;169:287\u201393.","journal-title":"Br J Dermatol."},{"key":"164_CR35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11630540-000000000-00000","volume":"13","author":"RM Bacigalupi","year":"2012","unstructured":"Bacigalupi RM, Postolova A, Davis RS. Evidence-based, non-surgical treatments for vitiligo: a review. Am J Clin Dermatol. 2012;13:217\u201337.","journal-title":"Am J Clin Dermatol."},{"key":"164_CR36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1590\/abd1806-4841.20142865","volume":"89","author":"Machado Filho CD","year":"2014","unstructured":"Machado Filho CD. Timoner FR. Epidermal curettage technique (ECT) for tissue harvest from the donor area for melanocyte autologous grafting in cases of vitiligo. An Bras Dermatol. 2014;89:681\u20133.","journal-title":"An Bras Dermatol."},{"key":"164_CR37","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-4632.2011.05454.x","volume":"51","author":"R Sapam","year":"2012","unstructured":"Sapam R, Agrawal S, Dhali TK. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study. Int J Dermatol. 2012;51:1107\u201315.","journal-title":"Int J Dermatol."},{"key":"164_CR38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0781.2009.00426.x","volume":"25","author":"A Akar","year":"2009","unstructured":"Akar A, Tunca M, Koc E, Kurumlu Z. Broadband targeted UVB phototherapy for localized vitiligo: a retrospective study. Photodermatol Photoimmunol Photomed. 2009;25:161\u20133.","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"164_CR39","doi-asserted-by":"crossref","unstructured":"Yazdani Abyaneh M, Griffith RD, Falto-Aizpurua L, Nouri K. Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: mechanisms and efficacies. J Eur Acad Dermatol Venereol. 2014;28:1610\u201322.","DOI":"10.1111\/jdv.12619"},{"key":"164_CR40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0781.2012.00648.x","volume":"28","author":"Z Hallaji","year":"2012","unstructured":"Hallaji Z, Ghiasi M, Eisazadeh A, Damavandi MR. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatol Photoimmunol Photomed. 2012;28:115\u20139.","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"164_CR41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/09546634.2013.777381","volume":"25","author":"N Akdeniz","year":"2014","unstructured":"Akdeniz N, Yavuz IH, Gunes Bilgili S, Ozayd\u0131n Yavuz G, Calka O. Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo. J Dermatolog Treat. 2014;25:196\u20139.","journal-title":"J Dermatolog Treat."},{"key":"164_CR42","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10103-012-1185-1","volume":"28","author":"AK Alhowaish","year":"2013","unstructured":"Alhowaish AK, Dietrich N, Onder M, Fritz K. Effectiveness of a 308-nm excimer laser in treatment of vitiligo: a review. Lasers Med Sci. 2013;28:1035\u201341.","journal-title":"Lasers Med Sci."},{"key":"164_CR43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2133.2012.11008.x","volume":"167","author":"KK Park","year":"2012","unstructured":"Park KK, Liao W, Murase JE. A review of monochromatic excimer light in vitiligo. Br J Dermatol. 2012;167:468\u201378.","journal-title":"Br J Dermatol."},{"issue":"Suppl 1","key":"164_CR44","first-page":"S44","volume":"25","author":"BW Lee","year":"2012","unstructured":"Lee BW, Schwartz RA, Hercogov\u00e1 J, Valle Y, Lotti TM. Vitiligo road map. Dermatol Ther. 2012;25(Suppl 1):S44\u201356.","journal-title":"Dermatol Ther."},{"issue":"Suppl 2","key":"164_CR45","first-page":"147","volume":"35","author":"V Bulat","year":"2011","unstructured":"Bulat V, Situm M, Dediol I, Ljubici\u0107 I, Bradi\u0107 L. The mechanisms of action of phototherapy in the treatment of the most common dermatoses. Coll Antropol. 2011;35(Suppl 2):147\u201351.","journal-title":"Coll Antropol."},{"key":"164_CR46","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.3390\/ijms14036414","volume":"14","author":"CH Lee","year":"2013","unstructured":"Lee CH, Wu SB, Hong CH, Yu HS, Wei YH. Molecular mechanisms of UV-induced apoptosis and its effects on skin residential cells: the implication in UV-based phototherapy. Int J Mol Sci. 2013;14:6414\u201335.","journal-title":"Int J Mol Sci."},{"issue":"Suppl 1","key":"164_CR47","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/dth.12008","volume":"25","author":"IV Korobko","year":"2012","unstructured":"Korobko IV. Review of current clinical studies of vitiligo treatments. Dermatol Ther. 2012;25(Suppl 1):S17\u201327.","journal-title":"Dermatol Ther."},{"key":"164_CR48","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1346-8138.2011.01323.x","volume":"39","author":"S Itoi","year":"2012","unstructured":"Itoi S, Tanemura A, Nishioka M, Sakimoto K, Iimuro E, Katayama I. Evaluation of the clinical safety and efficacy of a newly developed 308-nm excimer lamp for vitiligo vulgaris. J Dermatol. 2012;39:559\u201361.","journal-title":"J Dermatol."},{"key":"164_CR49","first-page":"8","volume":"5","author":"S Mehraban","year":"2004","unstructured":"Mehraban S, Feily A. 308 nm excimer laser in dermatology. J Lasers Med Sci. 2014;5:8\u201312.","journal-title":"J Lasers Med Sci"},{"key":"164_CR50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2310\/7750.2014.14002","volume":"19","author":"HA Al-Shobaili","year":"2015","unstructured":"Al-Shobaili HA. Treatment of vitiligo patients by excimer laser improves patients\u2019 quality of life. J Cutan Med Surg. 2015;19:50\u20136.","journal-title":"J Cutan Med Surg."},{"key":"164_CR51","first-page":"41","volume":"4","author":"JA Mouzakis","year":"2011","unstructured":"Mouzakis JA, Liu S, Cohen G. Rapid response of facial vitiligo to 308nm excimer laser and topical calcipotriene. J Clin Aesthet Dermatol. 2011;4:41\u20134.","journal-title":"J Clin Aesthet Dermatol."},{"key":"164_CR52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-4632.2009.03928.x","volume":"48","author":"O Welsh","year":"2009","unstructured":"Welsh O, Herz-Ruelas ME, G\u00f3mez M, Ocampo-Candiani J. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10\u00a0% of the body surface area. Int J Dermatol. 2009;48:529\u201334. doi: 10.1111\/j.1365-4632.2009.03928.x .","journal-title":"Int J Dermatol."},{"key":"164_CR53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4103\/0019-5154.139892","volume":"59","author":"I Majid","year":"2014","unstructured":"Majid I. Efficacy of targeted narrowband ultraviolet B therapy in vitiligo. Indian J Dermatol. 2014;59:485\u20139.","journal-title":"Indian J Dermatol."},{"key":"164_CR54","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jaad.2014.03.014","volume":"71","author":"F Kaliyadan","year":"2014","unstructured":"Kaliyadan F, Ashique KT. Optimizing the efficacy of targeted phototherapy by marking early vitiligo lesions after visualizing under a Wood\u2019s lamp. J Am Acad Dermatol. 2014;71:e69.","journal-title":"J Am Acad Dermatol."},{"issue":"Suppl 1","key":"164_CR55","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1111\/dth.12011","volume":"25","author":"TM Lotti","year":"2012","unstructured":"Lotti TM, Hercogov\u00e1 J, Schwartz RA, Tsampau D, Korobko I, Pietrzak A, et al. Treatments of vitiligo: what\u2019s new at the horizon. Dermatol Ther. 2012;25(Suppl 1):S32\u201340.","journal-title":"Dermatol Ther."},{"key":"164_CR56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0378-6323.90945","volume":"78","author":"IH Hamzavi","year":"2012","unstructured":"Hamzavi IH, Lim HW, Syed ZU. Ultraviolet-based therapy for vitiligo: what\u2019s new? Indian J Dermatol Venereol Leprol. 2012;78:42\u20138.","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"164_CR57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1468-3083.2012.04498.x","volume":"27","author":"KY Lee","year":"2013","unstructured":"Lee KY, Jeon SY, Hong JW, Choi KW, Lee CY, Choi SJ, et al. Endothelin-1 enhances the proliferation of normal human melanocytes in a paradoxical manner from the TNF-\u03b1-inhibited condition, but tacrolimus promotes exclusively the cellular migration without proliferation: a proposed action mechanism for combination therapy of phototherapy and topical tacrolimus in vitiligo treatment. J Eur Acad Dermatol Venereol. 2013;27:609\u201316.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"164_CR58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1600-0781.2010.00510.x","volume":"26","author":"R Noborio","year":"2010","unstructured":"Noborio R, Morita A. Preferential induction of endothelin-1 in a human epidermal equivalent model by narrow-band ultraviolet B light sources. Photodermatol Photoimmunol Photomed. 2010;26:159\u201361.","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"164_CR59","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/jid.2015.126","volume":"135","author":"NB Goldstein","year":"2015","unstructured":"Goldstein NB, Koster MI, Hoaglin LG, Spoelstra NS, Kechris KJ, Robinson SE, et al. Narrow band ultraviolet B treatment for human vitiligo is associated with proliferation, migration, and differentiation of melanocyte precursors. J Invest Dermatol. 2015;135:2068\u201376.","journal-title":"J Invest Dermatol."},{"key":"164_CR60","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/jid.2015.26","volume":"135","author":"JM Eby","year":"2015","unstructured":"Eby JM, Kang HK, Tully ST, Bindeman WE, Peiffer DS, Chatterjee S, et al. CCL22 to activate treg migration and suppress depigmentation in vitiligo. J Invest Dermatol. 2015;135:1574\u201380.","journal-title":"J Invest Dermatol."},{"key":"164_CR61","unstructured":"Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration, 2011. http:\/\/handbook.cochrane.org . Accessed Oct 26 2015."},{"key":"164_CR62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000335272","volume":"223","author":"E Verhaeghe","year":"2011","unstructured":"Verhaeghe E, Lodewick E, van Geel N, Lambert J. Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial. Dermatology. 2011;223:343\u20138.","journal-title":"Dermatology."},{"key":"164_CR63","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","volume":"21","author":"M Casacci","year":"2007","unstructured":"Casacci M, Thomas P, Pacifico A, Bonnevalle A, Paro Vidolin A, Leone G. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311\u2013313\u00a0nm) in the treatment of vitiligo\u2013a multicentre controlled study. J Eur Acad Dermatol Venereol. 2007;21:956\u201363.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"164_CR64","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/phpp.12015","volume":"29","author":"Q Shi","year":"2013","unstructured":"Shi Q, Li K, Fu J, Wang Y, Ma C, Li Q, et al. Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo\u2013a randomized bilateral comparison study. Photodermatol Photoimmunol Photomed. 2013;29:27\u201333.","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"164_CR65","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2133.2010.09778.x","volume":"163","author":"F Duff Le","year":"2010","unstructured":"Le Duff F, Fontas E, Giacchero D, Sillard L, Lacour JP, Ortonne JP, et al. 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol. 2010;163:188\u201392.","journal-title":"Br J Dermatol."},{"key":"164_CR66","first-page":"120","volume":"2","author":"Y Yan","year":"2013","unstructured":"Yan Y, Li J, Wang R, Zhong RP, Guo LH, Zhu MH. A randomized comparative clinical trial of 308 monochromatic excimer light and 311\u00a0nm narrow-band ultraviolet in treating vitiligo [in Chinese]. J Clin Dermatol. 2013;2:120\u20133.","journal-title":"J Clin Dermatol"},{"key":"164_CR67","first-page":"58","volume":"6","author":"YB Liu","year":"2013","unstructured":"Liu YB, Yang YF, Song LX, Shan YH, Wang Y, Ma TQ, et al. Comparison of 308 nm excimer laser and 308 nm excimer lamp in treatment of vitiligo [in Chinese]. Clin Misdiagnosis Mistherapy. 2013;6:58\u201361.","journal-title":"Clin Misdiagn Misther"},{"key":"164_CR68","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/pcmr.12077","volume":"26","author":"CC Lan","year":"2013","unstructured":"Lan CC, Yu HS, Lu JH, Wu CS, Lai HC. Irradiance, but not fluence, plays a crucial role in UVB-induced immature pigment cell development: new insights for efficient UVB phototherapy. Pigment Cell Melanoma Res. 2013;26:367\u201376.","journal-title":"Pigment Cell Melanoma Res."},{"key":"164_CR69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/09546634.2014.991268","volume":"26","author":"Y Sun","year":"2015","unstructured":"Sun Y, Wu Y, Xiao B, Li L, Chen HD, Gao XH. Treatment of 308-nm excimer laser on vitiligo: a systemic review of randomized controlled trials. J Dermatolog Treat. 2015;26:347\u201353.","journal-title":"J Dermatolog Treat."},{"key":"164_CR70","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/09546634.2014.952610","volume":"26","author":"BH Xiao","year":"2015","unstructured":"Xiao BH, Wu Y, Sun Y, Chen HD, Gao XH. Treatment of vitiligo with NB-UVB: a systematic review. J Dermatolog Treat. 2015;26:340\u20136.","journal-title":"J Dermatolog Treat."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-015-0164-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0164-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T22:46:17Z","timestamp":1653432377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-015-0164-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,31]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1007\/s40257-015-0164-2","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,31]]}}}